abstract |
The present invention treats and treats cancers (eg, estrogen receptor positive (ER + ) breast cancer) by administering eribulin (eg, eribulin mesylate) in combination with a cyclin-dependent kinase (CDK) inhibitor. It features a method of treating and preventing the above-mentioned cancers in patients in need of prevention. |